Citation: Ziphozethu Ndlazi, Oualid Abboussi, Musa Mabandla, Willie Daniels. Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats[J]. AIMS Neuroscience, 2018, 5(4): 211-220. doi: 10.3934/Neuroscience.2018.4.211
[1] | Montoya ID, Bobes J (2015) Drugs of Abuse and Pharmacotherapies for Substance Use Disorders: An Introduction. Springer Milan, 315–317. |
[2] |
Haleem DJ, Ikram H, Haleem MA (2014) Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: Relationship with serotonin and dopamine in the striatum. Brain Res 1586: 73–82. doi: 10.1016/j.brainres.2014.06.022
![]() |
[3] |
Singh N, Pillay V, Choonara YE (2007) Advances in the treatment of Parkinson's disease. Prog Neurobiol 81: 29–44. doi: 10.1016/j.pneurobio.2006.11.009
![]() |
[4] | Peskind ER, Potkin SG, Pomara N, et al. (2006) Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial. Am J Geriat Psychiat 14: 704–715. |
[5] |
Téllez C, Bustamante ML, Toro P, et al. (2006) Addiction to apomorphine: A clinical case‐centred discussion. Addiction 101: 1662–1665. doi: 10.1111/j.1360-0443.2006.01580.x
![]() |
[6] |
Papp M (1988) Different effects of short-and long-term treatment with imipramine on the apomorphine-and food-induced place preference conditioning in rats. Pharmacol Biochem Behav 30: 889–893. doi: 10.1016/0091-3057(88)90115-3
![]() |
[7] |
Campbell JC, Jeyamohan SB, De LCP, et al. (2014) Place conditioning to apomorphine in rat models of Parkinson's disease: Differences by dose and side-effect expression. Behav Brain Res 275: 114–119. doi: 10.1016/j.bbr.2014.09.002
![]() |
[8] |
Sam E, Verbeke N (1995) Free radical scavenging properties of apomorphine enantiomers and dopamine: Possible implication in their mechanism of action in Parkinsonism. J Neural Transm-Parkinson's Dis Dementia Sect 10: 115–127. doi: 10.1007/BF02251227
![]() |
[9] |
El-Bachá RS, Netter P, Minn A (1999) Mechanisms of apomorphine cytoxicity towards rat glioma C6 cells: Protection by bovine serum albumin and formation of apomorphine-protein conjugates. Neurosci Lett 263: 25–28. doi: 10.1016/S0304-3940(99)00088-9
![]() |
[10] |
Dos SER, Daval J, Koziel V, et al. (2001) Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants. Biochem Pharmacol 61: 73–85. doi: 10.1016/S0006-2952(00)00524-4
![]() |
[11] |
Kelley AE (2004) Memory and addiction: Shared neural circuitry and molecular mechanisms. Neuron 44: 161–179. doi: 10.1016/j.neuron.2004.09.016
![]() |
[12] |
Di CP, Everitt BJ (2001) Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25: 341–360. doi: 10.1016/S0893-133X(01)00235-4
![]() |
[13] | Chédotal A, Richards LJ (2010) Wiring the brain: The biology of neuronal guidance. Cold Spring Harbor Perspect Biol 2: a001917. |
[14] | Kozela E, Popik P (2002) The effects of NMDA receptor antagonists on acute morphine antinociception in mice. Amino Acids 23: 163–168. |
[15] |
Chen SL, Tao PL, Chu CH, et al. (2012) Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats. J Neuroimmune Pharmacol 7: 444–453. doi: 10.1007/s11481-011-9337-9
![]() |
[16] |
Overton PG, Clark D (1997) Burst firing in midbrain dopaminergic neurons. Brain Res Rev 25: 312–334. doi: 10.1016/S0165-0173(97)00039-8
![]() |
[17] |
Volkow ND, Fowler JS, Wang GJ, et al. (1993) Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169–177. doi: 10.1002/syn.890140210
![]() |
[18] | Carr GD, Fibiger HC, Phillips AG (1989) Conditioned place preference as a measure of drug reward. Neuropharmacol Basis Reward 41: 143–150. |
[19] |
Spyraki C, Fibiger HC, Phillips AG (1982) Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res 253: 185–193. doi: 10.1016/0006-8993(82)90685-0
![]() |
[20] |
Van dKD, Swerdlow NR, Koob GF (1983) Paradoxical reinforcing properties of apomorphine: Effects of nucleus accumbens and area postrema lesions. Brain Res 259: 111–118. doi: 10.1016/0006-8993(83)91071-5
![]() |
[21] | Lagreze WA, Knorle RM, Feuerstein T (1998) Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmolo Visual Sci 39: 1063–1066. |
[22] | Wise RA, Yokel RA, Dewit H (1976) Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats. Science 191: 1273–1275. |
[23] |
Baxter BL, Gluckman MI, Stein L, et al. (1974) Self-injection of apomorphine in the rat: Positive reinforcement by a dopamine receptor stimulant. Pharmacol Biochem Behav 2: 387–391. doi: 10.1016/0091-3057(74)90085-9
![]() |
[24] | Haleem DJ, Hasnat A, Shireen E, et al. (2005) Dopamine and serotonin neurotransmission in the reinforcing effects of alcohol and apomorphine. J Coll Physicians Surg Pak 15: 458–462. |
[25] | Tzschentke TM, Schmidt WJ (2000) Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit Rev Neurobiol 14: 131–142. |
[26] |
Chen G, Greengard P, Yan Z (2004) Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex. Proc Natl Acad Sci U. S. A 101: 2596–2600. doi: 10.1073/pnas.0308618100
![]() |
[27] |
Zweifel LS, Argilli E, Bonci A, et al. (2008) Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron 59: 486–496. doi: 10.1016/j.neuron.2008.05.028
![]() |
[28] |
Bisaga A, Comer SD, Ward AS, et al. (2001) The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology 157: 1–10. doi: 10.1007/s002130100739
![]() |
[29] |
Popik P, Wrobel M, Bisaga A (2006) Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology 31: 160–170. doi: 10.1038/sj.npp.1300760
![]() |
[30] |
Popik P, Layer RT, Skolnick P (1994) The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H] MK-801 binding to the NMDA receptor complex. Psychopharmacology 114: 672–674. doi: 10.1007/BF02245000
![]() |
[31] | Williams K, Dichter MA, Molinoff PB (1992) Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol Pharmacol 42: 147–151. |
[32] |
Wu PH, Mihic SJ, Liu JF, et al. (1993) Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801. Eur J Pharmacol 231: 157–164. doi: 10.1016/0014-2999(93)90444-M
![]() |
[33] |
Parsons CG (2001) NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol 429: 71–78. doi: 10.1016/S0014-2999(01)01307-3
![]() |
[34] |
Kemp JA, Mckernan RM (2002) NMDA receptor pathways as drug targets. Nat Neurosci 5: 1039–1042. doi: 10.1038/nn936
![]() |
[35] |
Popik P, Skolnick P (1996) The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacol Biochem Behav 53: 791–797. doi: 10.1016/0091-3057(95)02163-9
![]() |
[36] | Jeanblanc J, Coune F, Botia B, et al. (2015) Brain-derived neurotrophic factor mediates the suppression of alcohol self-administration by memantine. Addict Biol 19: 758–769. |
[37] |
Uys JD, Lalumiere RT (2008) Glutamate: The new frontier in pharmacotherapy for cocaine addiction. CNS Neurol Disord: Drug Targets 7: 482–491. doi: 10.2174/187152708786927868
![]() |
[38] |
Sattler R, Tymianski M (2000) Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 78: 3–13. doi: 10.1007/s001090000077
![]() |